Search Results 51-60 of 27601 for FMT and Ulcerative Colitis
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.
Fecal calprotectin level > 100 mg/g. For women of childbearing potential or men with a partner of childbearing potential, agree to use birth control methods ...
... ulcerative colitis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
... ulcerative colitis. Overall, bariatric surgery is a safe and effective option for patients with IBD . How does obesity impact patients with both IBD and ...
A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis. Print details. Share ...
To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...
Inflammatory bowel disease is an umbrella term that describes incurable disorders that involve chronic inflammation of the digestive tract. Ulcerative colitis ...
A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) ...
The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.